Aprea Therapeutics, Inc. (APRE): SCHEDULE 13G/A filed Nov 12, 2025

Form type

SCHEDULE 13G/A

Filing date

Nov 12, 2025

Accession number

0001214659-25-016261

Filer

Aprea Therapeutics, Inc. (CIK 1781983)